Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2023 Jan;22(1):34-44.
doi: 10.1002/pst.2256. Epub 2022 Jul 18.

A Bayesian piecewise exponential phase II design for monitoring a time-to-event endpoint

Affiliations
Clinical Trial

A Bayesian piecewise exponential phase II design for monitoring a time-to-event endpoint

Yun Qing et al. Pharm Stat. 2023 Jan.

Abstract

A robust Bayesian design is presented for a single-arm phase II trial with an early stopping rule to monitor a time to event endpoint. The assumed model is a piecewise exponential distribution with non-informative gamma priors on the hazard parameters in subintervals of a fixed follow up interval. As an additional comparator, we also define and evaluate a version of the design based on an assumed Weibull distribution. Except for the assumed models, the piecewise exponential and Weibull model based designs are identical to an established design that assumes an exponential event time distribution with an inverse gamma prior on the mean event time. The three designs are compared by simulation under several log-logistic and Weibull distributions having different shape parameters, and for different monitoring schedules. The simulations show that, compared to the exponential inverse gamma model based design, the piecewise exponential design has substantially better performance, with much higher probabilities of correctly stopping the trial early, and shorter and less variable trial duration, when the assumed median event time is unacceptably low. Compared to the Weibull model based design, the piecewise exponential design does a much better job of maintaining small incorrect stopping probabilities in cases where the true median survival time is desirably large.

Keywords: Bayesian adaptive design; futility monitoring; go/no-go decision; interim analysis.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Estimation of the survival distribution by the Kaplan–Meier method, or assuming either a Weibull or an exponential distribution
FIGURE 2
FIGURE 2
Estimation of the progression-free survival distribution by the Kaplan–Meier method, or assuming either a piecewise exponential or exponential distribution
FIGURE 3
FIGURE 3
User interface for the Shiny application of PE-G method

References

    1. Gehan EA. The determination of the number of patients required in a preliminary and a follow-up trial of a new chemotherapeutic agent. J Chronic Dis. 1961;13(4):346–353. - PubMed
    1. Simon R, Wittes RE, Ellenberg SS. Randomized phase II clinical trials. Cancer Treat Rep. 1985;69(12):1375–1381. - PubMed
    1. Thall PF, Sung HG. Some extensions and applications of a Bayesian strategy for monitoring multiple outcomes in clinical trials. Stat Med. 1998;17(14):1563–1580. - PubMed
    1. Rubinstein L, Crowley J, Ivy P, Leblanc M, Sargent D. Randomized phase II designs. Clin Cancer Res. 2009;15(6):1883–1890. - PMC - PubMed
    1. Fleming TR. One-sample multiple testing procedure for phase II clinical trials. Biometrics. 1982;38(1):143–151. - PubMed

Publication types